Jennifer A. Wargo

The University of Texas MD Anderson Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

UNC Libraries(2020)10.17615/a8zp-dq08

Top 100%

0DataRank

Top 100%0 citations

Andrew E. Aplin, Yiling Lu, Sébastien Jeay, Carol L. Shields, Michal Barzily-Rokni +49 more

Papers

Driven by 91 papers — median percentile 0. Top paper: “Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy”.

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Cell(2017)10.1016/j.cell.2017.01.017

N/A

12.7DataRank · unranked

5568 citations

Siwen Hu-Lieskovan, Jennifer A. Wargo, Antoni Ribas, Padmanee Sharma

Identification of bacteria-derived HLA-bound peptides in melanoma

Nature(2021)10.1038/s41586-021-03368-8

N/A

7.4DataRank · unranked

444 citations

Adi Nagler, Deborah Nejman, Michal Alon, Chaya Barbolin, Eilon Barnea +48 more

Embracing cancer complexity: Hallmarks of systemic disease

Cell(2024)10.1016/j.cell.2024.02.009

N/A

6.5DataRank · unranked

498 citations

Elsa Bernard, Chris Abbosh, Fabrice Andre, Johan Auwerx, Allan Balmain +28 more

The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View

Trends in cancer(2020)10.1016/j.trecan.2020.01.004

N/A

6.0DataRank · unranked

268 citations

Vincent B. Young, Joseph D. Skufca, Fiona Ginty, Traci L. Testerman, Alexander T. Pearson +25 more

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Cancer Cell(2022)10.1016/j.ccell.2022.04.004

N/A

4.7DataRank · unranked

350 citations

Daniel H. Johnson, Noha Abdel‐Wahab, Wai Chin Foo, Salah-Eddine Bentebibel, May Daher +32 more

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Nature Medicine(2023)10.1038/s41591-022-02189-0

N/A

4.1DataRank · unranked

213 citations

Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy +52 more

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-25188-0

N/A

3.1DataRank · unranked

110 citations

Annikka Weissferdt, Myrna C. B. Godoy, William N. William, Cheuk Hong Leung, Heather Lin +23 more

Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0144

N/A

2.0DataRank · unranked

79 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

Nature Medicine(2023)10.1038/s41591-022-02170-x

N/A

1.9DataRank · unranked

83 citations

Sherise D. Ferguson, Roland L. Bassett, Alexandra P. Foster, Ida John, Tarin Hennegan +32 more

Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)

Neoplasia(2022)10.1016/j.neo.2022.100813

N/A

1.4DataRank · unranked

54 citations

Vancheswaran Gopalakrishnan, Amani M. Harrandah, Tatiana V. Karpinets, Rekha Garg, Randy Chu +16 more

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Science(2018)10.1126/science.aan4236

N/A

1.3DataRank · unranked

4585 citations

C. N. Spencer, Luigi Nezi, Alexandre Reuben, Miles C. Andrews, Tatiana V. Karpinets +89 more

B cells and tertiary lymphoid structures promote immunotherapy response

Nature(2020)10.1038/s41586-019-1922-8

N/A

1.2DataRank · unranked

2719 citations

Sangeetha M. Reddy, Jianjun Gao, Shaojun Zhang, Rafet Başar, Rohit Thakur +55 more

The human tumor microbiome is composed of tumor type–specific intracellular bacteria

Science(2020)10.1126/science.aay9189

N/A

1.2DataRank · unranked

2272 citations

Ilana Livyatan, Garold Fuks, Nancy Gavert, Yaara Zwang, Leore T. Geller +56 more

B cells are associated with survival and immunotherapy response in sarcoma

Nature(2020)10.1038/s41586-019-1906-8

N/A

1.1DataRank · unranked

1962 citations

Aurélien de Reyniès, Emily Z. Keung, Tom Wei‐Wu Chen, Cheng‐Ming Sun, Julien Caldéraro +24 more

Hallmarks of response, resistance, and toxicity to immune checkpoint blockade

Cell(2021)10.1016/j.cell.2021.09.020

N/A

1.1DataRank · unranked

1668 citations

Beth A. Helmink, Padmanee Sharma, Jennifer A. Wargo, Golnaz Morad

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Cancer Discovery(2016)10.1158/2159-8290.cd-15-1545

N/A

1.0DataRank · unranked

1012 citations

Whijae Roh, Alexandre Reuben, Zachary A. Cooper, Christine N. Spencer, Peter A. Prieto +39 more

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

Cell Reports Medicine(2022)10.1016/j.xcrm.2021.100500

N/A

0.972DataRank · unranked

35 citations

Moshe Sade-Feldman, Jaegil Kim, Chip Stewart, Anna Gonye, Arvind Ravi +34 more

Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment

Cell(2021)10.1016/j.cell.2021.09.019

N/A

0.953DataRank · unranked

575 citations

Romina E. Araya, April Huang, Quanyi Chen, Martina Di Modica, Richard R. Rodrigues +10 more

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine(2021)10.1038/s41591-021-01406-6

N/A

0.910DataRank · unranked

429 citations

Connie P. M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, W. S. Chen, Lisa Derosa +66 more

Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells

The Journal of Experimental Medicine(2020)10.1084/jem.20191920

N/A

0.876DataRank · unranked

342 citations

Boone M. Prentice, Kristin G. Anderson, Ayush T. Raman, Aislyn Schalck, Gabriela S. Codreanu +23 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring

Cancer Cell(2023)10.1016/j.ccell.2023.09.012

N/A

0.827DataRank · unranked

247 citations

Molly B. El Alam, Rui Wang, Tatiana V. Karpinets, David Lo, Erica J. Lynn +40 more

Multi-modal molecular programs regulate melanoma cell state

Nature Communications(2022)10.1038/s41467-022-31510-1

N/A

0.812DataRank · unranked

26 citations

Junna Oba, Chang‐Jiun Wu, Haifeng Zhu, Tatiana V. Karpinets, Caitlin Creasy +31 more

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1824

N/A

0.807DataRank · unranked

216 citations

Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack +18 more

PPP2R1A mutations portend improved survival after cancer immunotherapy

Nature(2025)10.1038/s41586-025-09203-8

N/A

0.793DataRank · unranked

30 citations

Anne Knisely, Mitsutake Yano, Minghao Dang, Emily Hinchcliff, Sanghoon Lee +36 more

Targeting PD-L2–RGMb overcomes microbiome-related immunotherapy resistance

Nature(2023)10.1038/s41586-023-06026-3

N/A

0.786DataRank · unranked

188 citations

Francesca S. Gazzaniga, Meng–Huang Wu, Amalia K. Luthens, Jacob E. Gillis, Wenfeng Zheng +11 more

Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy

Nature Communications(2021)10.1038/s41467-020-20600-7

N/A

0.784DataRank · unranked

185 citations

Thomas Connelly, Robin Choi, Hyeree Choi, Anastasia Samarkina, Ling Li +52 more

Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells

Nature(2023)10.1038/s41586-023-06342-8

N/A

0.782DataRank · unranked

183 citations

Gianna T. Busch, Maalavika Pillai, Jingxin Li, Ryan H. Boe, Emanuelle I. Grody +30 more

Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0088

N/A

0.780DataRank · unranked

23 citations

Laura Reyes-Uribe, Johannes F. Fahrmann, Whittney S. Thoman, Mark F. Munsell, Jennifer B. Dennison +21 more

Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

Communications Biology(2021)10.1038/s42003-021-01741-x

N/A

0.736DataRank · unranked

134 citations

Molly B. El Alam, Tatiana V. Karpinets, Stephanie Dorta‐Estremera, Venkatesh L. Hegde, Sita M.K. Nookala +19 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Nature(2022)10.1038/s41586-022-04833-8

N/A

0.731DataRank · unranked

130 citations

Michael G. White, Miles C. Andrews, Manoj Chelvanambi, Russell G. Witt, Joseph R. Daniele +60 more

Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy

Nature Reviews Clinical Oncology(2023)10.1038/s41571-023-00785-8

N/A

0.728DataRank · unranked

127 citations

Marine Fidelle, Bertrand Routy, Guido Kroemer, Jennifer A. Wargo, Nicola Segata +2 more

Integrative multi-omics analysis uncovers tumor-immune-gut axis influencing immunotherapy outcomes in ovarian cancer

Nature Communications(2024)10.1038/s41467-024-54565-8

N/A

0.702DataRank · unranked

34 citations

Mark D. Long, Shanmuga Reddy Chilakapati, Eduardo Cortes Gomez, Sebastiano Battaglia, Prashant Singh +12 more

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

The Journal of Experimental Medicine(2022)10.1084/jem.20221333

N/A

0.626DataRank · unranked

64 citations

Yusra B. Medik, Bhakti Patel, Daniel Zamler, Sijie Chen, Thomas Chapman +39 more

Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment

Science Translational Medicine(2022)10.1126/scitranslmed.abo3445

N/A

0.624DataRank · unranked

63 citations

Diana H. Wiesnoski, Chia‐Chi Chang, Wen-Bin Tsai, Dung Pham, Saira Ahmed +54 more

Glioma and the gut–brain axis: opportunities and future perspectives

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac054

N/A

0.619DataRank · unranked

61 citations

Jack Nickles, Ana G. Rodriguez-Armendariz, Braden C. McFarland, Nadim J. Ajami, Leomar Y. Ballester +3 more

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer(2024)10.1038/s43018-024-00726-z

N/A

0.612DataRank · unranked

58 citations

Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin +54 more

Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma

Nature Communications(2020)10.1038/s41467-020-14632-2

N/A

0.542DataRank · unranked

36 citations

Piyushkumar A. Mundra, Sara Valpione, Pablo García‐Martínez, Matthew Smith, Jonathan Greenall +17 more

Activated B cells suppress T-cell function through metabolic competition

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005644

N/A

0.542DataRank · unranked

36 citations

Rafet Başar, Yuefan Huang, Fang Wang, Natalia Baran, Pinaki P. Banerjee +22 more

Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2661

N/A

0.542DataRank · unranked

36 citations

Ashley V. Menk, Dayana B. Rivadeneira, Ryan C. Augustin, Mingchu Xu, Jun Li +47 more

Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

Annals of Oncology(2020)10.1016/j.annonc.2020.07.016

N/A

0.538DataRank · unranked

35 citations

Chandra Mani Adhikari, Serigne Lo, Robert V. Rawson, Rodabe N. Amaria, Alexander M. Menzies +16 more

Microbiome influencers of checkpoint blockade–associated toxicity

The Journal of Experimental Medicine(2023)10.1084/jem.20220948

N/A

0.533DataRank · unranked

34 citations

Robert R. Jenq, Jennifer A. Wargo, Stephanie S. Watowich, Yinghong Wang

Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease

Cell Host & Microbe(2024)10.1016/j.chom.2024.08.004

N/A

0.533DataRank · unranked

34 citations

Tomo Hayase, Akash Mukherjee, Stuart C Stinson, Mohamed A. Jamal, Miriam R. Ortega +50 more

Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1

Nature Communications(2021)10.1038/s41467-021-24293-4

N/A

0.505DataRank · unranked

28 citations

Alphonsus H. C. Ng, Frances Chow, Richard G. Everson, Beth A. Helmink, Michael T. Tetzlaff +6 more

Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0469

N/A

0.489DataRank · unranked

25 citations

Yuejiang Liu, Fuduan Peng, Sujuan Yang, Mohamed A. Jamal, Manvi Sharma +30 more

HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development

Frontiers in Immunology(2023)10.3389/fimmu.2023.1051431

N/A

0.464DataRank · unranked

21 citations

Victoria O. Huynh, Daniel Lin, R. Tyler Hillman, Chike O. Abana, Molly B. El Alam +20 more

Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-1083

N/A

0.453DataRank · unranked

6 citations

Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete +27 more

Uncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review

Seminars in Hematology(2020)10.1053/j.seminhematol.2020.05.002

N/A

0.449DataRank · unranked

19 citations

Gabriel O Ologun, Jennifer A. Wargo, Taylor M. Halsey

Microbial signals in primary and metastatic brain tumors

Nature Medicine(2025)10.1038/s41591-025-03957-4

N/A

0.449DataRank · unranked

19 citations

Ashish Damania, Brenda Melendez, Bharat Singh, Fabiana J. Veguilla, Rebecca Soto +61 more

Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0119

N/A

0.406DataRank · unranked

14 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia

Annals of Oncology(2023)10.1016/j.annonc.2023.06.007

N/A

0.396DataRank · unranked

13 citations

Joshua W.D. Tobin, Yongwoo David Seo, Georgina Gener‐Ricos, Emily Z. Keung, Elizabeth M. Burton +28 more

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf -mutated melanoma

OncoImmunology(2021)10.1080/2162402x.2021.1992880

N/A

0.385DataRank · unranked

12 citations

Robert Szczepaniak‐Sloane, Russell G. Witt, Alexandre Reuben, Pierre Olivier Gaudreau, Miles C. Andrews +27 more

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes

Cancers(2021)10.3390/cancers13215301

N/A

0.385DataRank · unranked

12 citations

Michael G. White, Russell G. Witt, Anik Banerjee, Michael A. Davies, Guangchun Han +18 more

Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade

Research Square(2023)10.21203/rs.3.rs-3161761/v1

N/A

0.360DataRank · unranked

10 citations

Erez N. Baruch, Priyadahrshini Nagarajan, Frederico O. Gleber‐Netto, Xiayu Rao, Tongxin Xie +34 more

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.03.450733

N/A

0.358DataRank · unranked

7 citations

Moshe Sade-Feldman, Jaegil Kim, Chip Stewart, Anna Gonye, Arvind Ravi +34 more

Immunotherapy response-associated Akkermansia: canary in a coal mine?

Trends in Immunology(2022)10.1016/j.it.2022.03.007

N/A

0.345DataRank · unranked

9 citations

Manoj Chelvanambi, Jennifer A. Wargo, Tina Cascone

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

OncoImmunology(2025)10.1080/2162402x.2025.2546402

N/A

0.323DataRank · unranked

7 citations

Simin Kiany, Marie‐Andrée Forget, Roland L. Bassett, Michael A. Davies, Adi Diab +15 more

Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0362

N/A

0.312DataRank · unranked

7 citations

Brenda Melendez, Qian Zhang, Richard K. Yang, Bryan Fellman, Barrett C. Lawson +11 more

Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.31.506051

N/A

0.300DataRank · unranked

4 citations

Alvin Shi, Ming Tang, Marcus Ho, Christopher Terranova, Kyriaki Galani +36 more

Bacteroides ovatus alleviates dysbiotic microbiota-induced intestinal graft-versus-host disease

Research Square(2023)10.21203/rs.3.rs-2460097/v1

N/A

0.292DataRank · unranked

6 citations

Eiko Hayase, Tomo Hayase, Akash Mukherjee, Stuart C Stinson, Mohamed A. Jamal +35 more

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9523

N/A

0.259DataRank · unranked

4 citations

Christopher P. Vellano, Miles C. Andrews, Russell G. Witt, Manoj Chelvanambi, Jennifer L. McQuade +15 more

Engineering immunity: bacterial delivery of cancer neoantigen vaccines

Trends in Immunology(2024)10.1016/j.it.2024.11.007

N/A

0.241DataRank · unranked

4 citations

Jennifer A. Wargo, Christopher D. Johnston

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

(2022)10.52519/00101

N/A

0.208DataRank · unranked

3 citations

Yusra B. Medik, Bhakti K. Patel, Daniel B. Zamler, Sijie Chen, T. Chapman +39 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0.165DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Longitudinal single-cell (sc) immune profiling of cerebrospinal fluid (CSF) from melanoma patients (pts) with leptomeningeal disease (LMD) treated with intrathecal (IT) and intravenous (IV) nivolumab (N).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2015

N/A

0.113DataRank · unranked

1 citations

Yitao Yang, Sheila Duncan, Sherise D. Ferguson, Jennifer A. Wargo, Elizabeth M. Burton +5 more

Gut microbiome diversity as an independent predictor of survival in cervical cancer patients receiving chemoradiation.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6036

N/A

0.104DataRank · unranked

1 citations

Molly B. El Alam, Tatiana V. Karpinets, Kyoko Yoshida-Court, Greyson Biegert, Mustapha Ahmed-Kaddar +15 more

Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier

Nutrients(2025)10.3390/nu18010040

N/A

0.104DataRank · unranked

1 citations

Satabdi Saha, Nazli Dizman, Michelle Rohlfs, Elizabeth Sirmans, J. M. Gardner +17 more

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines

Research Square(2025)10.21203/rs.3.rs-4294379/v1

N/A

0.104DataRank · unranked

1 citations

Agathe Carrier, Paolo Manghi, Carolina Alves Costa Silva, Imran Lahmar, Roxanne Birebent +43 more

Candidate HPV-Specific T-Cells Expand in the Tumor Microenvironment During Chemoradiotherapy

Research Square(2021)10.21203/rs.3.rs-105933/v1

N/A

0DataRank · unranked

0 citations

Molly B. El Alam, Erica J. Lynn, Julianna K. Edwards, Tatiana V. Karpinets, Xiaogang Wu +39 more

Outcome of concurrent treatment with a-CTLA4 and metronidazole in murine model of colon adenocarcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e14566

N/A

0DataRank · unranked

4 citations

Yifan Zhou, Laura M. Kahn, Bhakti Patel, Rachel L. Babcock, Taylor T. Chrisikos +6 more

Fecal microbiota transplantation as a mean of overcoming immunotherapy-resistant cancers – hype or hope?

Therapeutic Advances in Medical Oncology(2021)10.1177/17588359211045853

N/A

0DataRank · unranked

15 citations

Tanmay Gaglani, Jennifer A. Wargo, Erez N. Baruch

A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers

PLoS ONE(2021)10.1371/journal.pone.0247905

N/A

0DataRank · unranked

38 citations

Travis T. Sims, Ramez Kouzy, Greyson Biegert, Joseph Abi Jaoude, Tatiana V. Karpinets +17 more

Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect

Cancer Immunology Research(2021)10.1158/2326-6066.cir-20-0877

N/A

0DataRank · unranked

57 citations

Jingjing Wang, Jennifer A. Wargo, Erez N. Baruch

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma

UNC Libraries(2020)10.17615/a8zp-dq08

Top 100%

0DataRank

Top 100%0 citations

Andrew E. Aplin, Yiling Lu, Sébastien Jeay, Carol L. Shields, Michal Barzily-Rokni +49 more

Tumoral microbial and pathway alterations associated with young-onset rectal cancer and its response to therapy.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.3_suppl.160

N/A

0DataRank · unranked

2 citations

Ashish Damania, Jumanah Alshenaifi, Pranoti Sahasrabhojane, Oliver Peacock, Jillian Losh +9 more

TARO: tree-aggregated factor regression for microbiome data integration

Bioinformatics(2024)10.1093/bioinformatics/btae321

N/A

0DataRank · unranked

0 citations

Iqbal Mahmud, Philip L. Lorenzi, Robert R. Jenq, Jennifer A. Wargo, Nadim J. Ajami +2 more

A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma

Nature Biomedical Engineering(2025)10.1038/s41551-024-01318-z

N/A

0DataRank · unranked

63 citations

Serena Galié, Punit Tyagi, Carlotta Catozzi, Hariam Raji, Amir Nabinejad +17 more

Androgen receptor activity promotes resistance to BRAF-targeted melanoma therapy

Research Square(2020)10.21203/rs.3.rs-58480/v1

N/A

0DataRank · unranked

0 citations

Christopher P. Vellano, Michael White, Miles C. Andrews, Joseph R. Daniele, Mark Titus +41 more

Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest

Cancer Cell(2025)10.1016/j.ccell.2025.09.010

N/A

0DataRank · unranked

26 citations

Falk Ponath, Victor A. Ajisafe, Clara R. Becker, Andrew G. Kempchinsky, Martha A. Zepeda‐Rivera +16 more

Investigating the tumor immune infiltrate for populations that predict immune-related adverse events (irAEs) in patients receiving PD-1 inhibitors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3116

N/A

0DataRank · unranked

0 citations

Neal P. Smith, Moshe Sade-Feldman, Dennie T. Frederick, Russell W. Jenkins, Justine V. Cohen +13 more

The bacterial microbiome modulates the initiation of brain metastasis by impacting the gut-to-brain axis

iScience(2025)10.1016/j.isci.2025.111874

N/A

0DataRank · unranked

8 citations

Michelle Ballabio, Bastien Dolfi, Golnaz Morad, Vladimir Wischnewski, Eleni Lamprou +13 more

Adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.10.036426

N/A

0DataRank · unranked

2 citations

Travis T. Sims, Ramez Kouzy, Greyson Biegert, Joseph Abi Jaoude, Tatiana V. Karpinets +17 more

Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

medRxiv(2020)10.1101/2020.05.18.20105809

N/A

0DataRank · unranked

11 citations

Molly B. El Alam, Tatiana V. Karpinets, Stephanie Dorta‐Estremera, Venkatesh L. Hegde, Sita M.K. Nookala +19 more

Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma

Cancers(2023)10.3390/cancers15143630

N/A

0DataRank · unranked

7 citations

Sridevi Addanki, Yi‐Ju Chiang, Salyna Meas, Vanessa N. Sarli, Joshua Upshaw +6 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597

N/A

0DataRank · unranked

0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530597.v1

N/A

0DataRank · unranked

0 citations

Er-Yen Yen, Jeffrey T. Chang, Roland L. Bassett, Gheath Alatrash, Haven R. Garber +26 more

Data from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

(2023)10.1158/2326-6066.c.6550526

N/A

0DataRank · unranked

0 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

(2023)10.1158/2326-6066.c.6550763

N/A

0DataRank · unranked

0 citations

Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete +27 more

Supplemental Tables from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/2326-6066.22544087.v1

Top 100%

0DataRank

Top 100%0 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma

(2023)10.1158/2326-6066.c.6550763.v1

N/A

0DataRank · unranked

0 citations

Caitlin J. Jones, Charlotte E. Ariyan, Zheng Zeng, Mono Pirun, Daniel A. Navarrete +27 more

TARO: tree-aggregated factor regression for microbiome data integration

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.17.562792

N/A

0DataRank · unranked

0 citations

Iqbal Mahmud, Philip L. Lorenzi, Robert R. Jenq, Jennifer A. Wargo, Nadim J. Ajami +2 more

Jennifer A. Wargo

Indexed papers

Top data-sharing exemplar

Papers